论文部分内容阅读
目的:分析米氮平与易蒙停在腹泻型肠易激综合征治疗中的应用价值。方法:选取我院收治的腹泻型肠易激综合征患者72例,随机分为观察组与对照组,观察组给予米氮平治疗,对照组给予易蒙停治疗,对比分析两组研究对象治疗前后心理状态变化情况及有效率。结果:治疗后,观察组患者焦虑、抑郁评分均低于对照组,数据差异显著(P<0.05);观察组总有效率为94.44%,高于对照组的77.78%,数据差异显著(P<0.05)。结论:在腹泻型肠易激综合征治疗中米氮平的治疗效果显著。
Objective: To analyze the clinical value of mirtazapine and simvastatin in the treatment of diarrhea-predominant irritable bowel syndrome. Methods: Seventy-two patients with diarrhea-predominant irritable bowel syndrome admitted to our hospital were randomly divided into the observation group and the control group. The observation group was treated with mirtazapine and the control group was given Yi-Meng-stop treatment. The two groups were compared and analyzed Psychological changes before and after the situation and efficiency. Results: After treatment, the anxiety and depression scores in the observation group were lower than those in the control group (P <0.05). The total effective rate in the observation group was 94.44%, which was significantly higher than that in the control group (77.78%, P < 0.05). Conclusion: The treatment effect of mirtazapine in diarrhea-predominant irritable bowel syndrome is significant.